NL1003300C2 - Implanteerbare therapeutische inrichting. - Google Patents

Implanteerbare therapeutische inrichting. Download PDF

Info

Publication number: NL1003300C2
Authority: NL; Netherlands
Prior art keywords: tube; therapeutic; cell; layer; therapeutic device
Prior art date: 1995-06-07

Application number

NL1003300A

Other languages

English (en)

Dutch (nl)

Other versions

NL1003300A1 (nl

Inventor

Mark Damon Butler

Stanley Lawrence Mish

Daniel Francis Davidson

James William Moore Iii

Original Assignee

Gore Hybrid Technologies Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-07

Filing date

1996-06-07

Publication date

1997-03-20

1996-06-07 Application filed by Gore Hybrid Technologies Inc filed Critical Gore Hybrid Technologies Inc

1996-12-10 Publication of NL1003300A1 publication Critical patent/NL1003300A1/xx

1997-03-20 Application granted granted Critical

1997-03-20 Publication of NL1003300C2 publication Critical patent/NL1003300C2/nl

Links

230000001225 therapeutic effect Effects 0.000 title claims description 130
239000000463 material Substances 0.000 claims description 251
-1 polytetrafluoroethylene Polymers 0.000 claims description 66
239000004810 polytetrafluoroethylene Substances 0.000 claims description 55
229920001343 polytetrafluoroethylene Polymers 0.000 claims description 53
239000000017 hydrogel Substances 0.000 claims description 45
239000011148 porous material Substances 0.000 claims description 28
239000012530 fluid Substances 0.000 claims description 21
230000002792 vascular Effects 0.000 claims description 21
239000003795 chemical substances by application Substances 0.000 claims description 18
239000000203 mixture Substances 0.000 claims description 15
238000001415 gene therapy Methods 0.000 claims description 13
238000012377 drug delivery Methods 0.000 claims description 11
238000005259 measurement Methods 0.000 claims description 10
239000003814 drug Substances 0.000 claims description 8
229940124597 therapeutic agent Drugs 0.000 claims description 8
235000010443 alginic acid Nutrition 0.000 claims description 5
229920000615 alginic acid Polymers 0.000 claims description 5
210000000056 organ Anatomy 0.000 claims description 5
239000000126 substance Substances 0.000 claims description 4
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 3
108010035532 Collagen Proteins 0.000 claims description 3
102000008186 Collagen Human genes 0.000 claims description 3
239000004698 Polyethylene Substances 0.000 claims description 3
239000004743 Polypropylene Substances 0.000 claims description 3
229940072056 alginate Drugs 0.000 claims description 3
229920001436 collagen Polymers 0.000 claims description 3
238000011049 filling Methods 0.000 claims description 3
229920000573 polyethylene Polymers 0.000 claims description 3
229920001155 polypropylene Polymers 0.000 claims description 3
229920000936 Agarose Polymers 0.000 claims description 2
102000008946 Fibrinogen Human genes 0.000 claims description 2
108010049003 Fibrinogen Proteins 0.000 claims description 2
108010010803 Gelatin Proteins 0.000 claims description 2
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 2
239000002033 PVDF binder Substances 0.000 claims description 2
239000004372 Polyvinyl alcohol Substances 0.000 claims description 2
239000000783 alginic acid Substances 0.000 claims description 2
229960001126 alginic acid Drugs 0.000 claims description 2
150000004781 alginic acids Chemical class 0.000 claims description 2
239000000679 carrageenan Substances 0.000 claims description 2
235000010418 carrageenan Nutrition 0.000 claims description 2
229920001525 carrageenan Polymers 0.000 claims description 2
229940113118 carrageenan Drugs 0.000 claims description 2
229960005188 collagen Drugs 0.000 claims description 2
229940012952 fibrinogen Drugs 0.000 claims description 2
229920000159 gelatin Polymers 0.000 claims description 2
239000008273 gelatin Substances 0.000 claims description 2
229940014259 gelatin Drugs 0.000 claims description 2
235000019322 gelatine Nutrition 0.000 claims description 2
235000011852 gelatine desserts Nutrition 0.000 claims description 2
229920002451 polyvinyl alcohol Polymers 0.000 claims description 2
229940068984 polyvinyl alcohol Drugs 0.000 claims description 2
229920002981 polyvinylidene fluoride Polymers 0.000 claims description 2
UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 2
229920002148 Gellan gum Polymers 0.000 claims 1
WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims 1
235000010492 gellan gum Nutrition 0.000 claims 1
239000000216 gellan gum Substances 0.000 claims 1
210000000496 pancreas Anatomy 0.000 claims 1
210000004027 cell Anatomy 0.000 description 109
229940058401 polytetrafluoroethylene Drugs 0.000 description 49
210000001519 tissue Anatomy 0.000 description 43
238000000034 method Methods 0.000 description 31
239000007788 liquid Substances 0.000 description 27
230000035699 permeability Effects 0.000 description 22
239000002861 polymer material Substances 0.000 description 21
210000004379 membrane Anatomy 0.000 description 19
239000012528 membrane Substances 0.000 description 19
238000002513 implantation Methods 0.000 description 16
238000007789 sealing Methods 0.000 description 12
239000007943 implant Substances 0.000 description 11
206010052428 Wound Diseases 0.000 description 8
208000027418 Wounds and injury Diseases 0.000 description 8
230000004907 flux Effects 0.000 description 8
238000002844 melting Methods 0.000 description 7
230000008018 melting Effects 0.000 description 7
229920001296 polysiloxane Polymers 0.000 description 7
239000005556 hormone Substances 0.000 description 6
229940088597 hormone Drugs 0.000 description 6
235000015097 nutrients Nutrition 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
210000002808 connective tissue Anatomy 0.000 description 5
238000005538 encapsulation Methods 0.000 description 5
238000001746 injection moulding Methods 0.000 description 5
238000001000 micrograph Methods 0.000 description 5
229920000642 polymer Polymers 0.000 description 5
239000000843 powder Substances 0.000 description 5
230000008569 process Effects 0.000 description 5
239000002699 waste material Substances 0.000 description 5
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 4
239000005977 Ethylene Substances 0.000 description 4
230000000712 assembly Effects 0.000 description 4
238000000429 assembly Methods 0.000 description 4
230000008901 benefit Effects 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
239000002775 capsule Substances 0.000 description 4
229920001577 copolymer Polymers 0.000 description 4
230000001419 dependent effect Effects 0.000 description 4
238000010030 laminating Methods 0.000 description 4
239000000565 sealant Substances 0.000 description 4
238000007920 subcutaneous administration Methods 0.000 description 4
210000003556 vascular endothelial cell Anatomy 0.000 description 4
YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 3
241000282537 Mandrillus sphinx Species 0.000 description 3
241001465754 Metazoa Species 0.000 description 3
206010029113 Neovascularisation Diseases 0.000 description 3
241000700159 Rattus Species 0.000 description 3
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
244000273618 Sphenoclea zeylanica Species 0.000 description 3
239000002870 angiogenesis inducing agent Substances 0.000 description 3
239000003181 biological factor Substances 0.000 description 3
230000006835 compression Effects 0.000 description 3
238000007906 compression Methods 0.000 description 3
238000011109 contamination Methods 0.000 description 3
238000001816 cooling Methods 0.000 description 3
239000006185 dispersion Substances 0.000 description 3
239000011737 fluorine Substances 0.000 description 3
229910052731 fluorine Inorganic materials 0.000 description 3
238000010562 histological examination Methods 0.000 description 3
239000004615 ingredient Substances 0.000 description 3
210000000265 leukocyte Anatomy 0.000 description 3
230000001050 lubricating effect Effects 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
239000011159 matrix material Substances 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 3
125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 3
239000000243 solution Substances 0.000 description 3
241000894007 species Species 0.000 description 3
239000010935 stainless steel Substances 0.000 description 3
229910001220 stainless steel Inorganic materials 0.000 description 3
239000007858 starting material Substances 0.000 description 3
229940126585 therapeutic drug Drugs 0.000 description 3
229920001169 thermoplastic Polymers 0.000 description 3
239000004416 thermosoftening plastic Substances 0.000 description 3
238000004804 winding Methods 0.000 description 3
230000029663 wound healing Effects 0.000 description 3
WWYNJERNGUHSAO-XUDSTZEESA-N (+)-Norgestrel Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-XUDSTZEESA-N 0.000 description 2
239000004215 Carbon black (E152) Substances 0.000 description 2
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
108090000695 Cytokines Proteins 0.000 description 2
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
102000018233 Fibroblast Growth Factor Human genes 0.000 description 2
108050007372 Fibroblast Growth Factor Proteins 0.000 description 2
102100031372 Thymidine phosphorylase Human genes 0.000 description 2
108700023160 Thymidine phosphorylases Proteins 0.000 description 2
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
230000003187 abdominal effect Effects 0.000 description 2
239000000853 adhesive Substances 0.000 description 2
230000001070 adhesive effect Effects 0.000 description 2
238000004873 anchoring Methods 0.000 description 2
230000033115 angiogenesis Effects 0.000 description 2
230000002491 angiogenic effect Effects 0.000 description 2
VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Substances [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
239000000919 ceramic Substances 0.000 description 2
230000012085 chronic inflammatory response Effects 0.000 description 2
239000003433 contraceptive agent Substances 0.000 description 2
230000002254 contraceptive effect Effects 0.000 description 2
230000008602 contraction Effects 0.000 description 2
239000010949 copper Substances 0.000 description 2
229910052802 copper Inorganic materials 0.000 description 2
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
210000003372 endocrine gland Anatomy 0.000 description 2
239000000835 fiber Substances 0.000 description 2
229940126864 fibroblast growth factor Drugs 0.000 description 2
210000004907 gland Anatomy 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
229930195733 hydrocarbon Natural products 0.000 description 2
150000002430 hydrocarbons Chemical class 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
238000011068 loading method Methods 0.000 description 2
230000007774 longterm Effects 0.000 description 2
239000004745 nonwoven fabric Substances 0.000 description 2
206010033675 panniculitis Diseases 0.000 description 2
239000002953 phosphate buffered saline Substances 0.000 description 2
239000004417 polycarbonate Substances 0.000 description 2
229920000515 polycarbonate Polymers 0.000 description 2
229920000728 polyester Polymers 0.000 description 2
230000004044 response Effects 0.000 description 2
230000004936 stimulating effect Effects 0.000 description 2
210000004304 subcutaneous tissue Anatomy 0.000 description 2
239000000758 substrate Substances 0.000 description 2
229910052719 titanium Inorganic materials 0.000 description 2
239000010936 titanium Substances 0.000 description 2
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
230000035899 viability Effects 0.000 description 2
238000009736 wetting Methods 0.000 description 2
WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
101150028074 2 gene Proteins 0.000 description 1
LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical class [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
229910000531 Co alloy Inorganic materials 0.000 description 1
229910000599 Cr alloy Inorganic materials 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
241000143637 Eleocharis confervoides Species 0.000 description 1
229920002449 FKM Polymers 0.000 description 1
102100037362 Fibronectin Human genes 0.000 description 1
108010067306 Fibronectins Proteins 0.000 description 1
MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
206010021143 Hypoxia Diseases 0.000 description 1
108010085895 Laminin Proteins 0.000 description 1
102000007547 Laminin Human genes 0.000 description 1
229920000459 Nitrile rubber Polymers 0.000 description 1
239000005642 Oleic acid Substances 0.000 description 1
ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
239000004952 Polyamide Substances 0.000 description 1
239000005062 Polybutadiene Substances 0.000 description 1
239000004793 Polystyrene Substances 0.000 description 1
229920006362 Teflon® Polymers 0.000 description 1
241000700605 Viruses Species 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
239000008272 agar Substances 0.000 description 1
230000000735 allogeneic effect Effects 0.000 description 1
239000000956 alloy Substances 0.000 description 1
229910045601 alloy Inorganic materials 0.000 description 1
125000003275 alpha amino acid group Chemical group 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
210000003567 ascitic fluid Anatomy 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
229910052788 barium Inorganic materials 0.000 description 1
DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
238000005452 bending Methods 0.000 description 1
239000000560 biocompatible material Substances 0.000 description 1
230000008512 biological response Effects 0.000 description 1
230000017531 blood circulation Effects 0.000 description 1
239000005388 borosilicate glass Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000011575 calcium Substances 0.000 description 1
235000010216 calcium carbonate Nutrition 0.000 description 1
239000001506 calcium phosphate Substances 0.000 description 1
235000011010 calcium phosphates Nutrition 0.000 description 1
OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical class [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
235000011132 calcium sulphate Nutrition 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
230000030833 cell death Effects 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
229910010293 ceramic material Inorganic materials 0.000 description 1
239000000788 chromium alloy Substances 0.000 description 1
239000010941 cobalt Substances 0.000 description 1
GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
239000002131 composite material Substances 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000012258 culturing Methods 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
239000008367 deionised water Substances 0.000 description 1
229910021641 deionized water Inorganic materials 0.000 description 1
239000004205 dimethyl polysiloxane Substances 0.000 description 1
238000007599 discharging Methods 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
230000004064 dysfunction Effects 0.000 description 1
210000003989 endothelium vascular Anatomy 0.000 description 1
229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
238000001125 extrusion Methods 0.000 description 1
239000004744 fabric Substances 0.000 description 1
239000003925 fat Substances 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
229920002313 fluoropolymer Polymers 0.000 description 1
239000004811 fluoropolymer Substances 0.000 description 1
239000000499 gel Substances 0.000 description 1
108010038983 glycyl-histidyl-lysine Proteins 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
239000010931 gold Substances 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
230000012010 growth Effects 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
235000012907 honey Nutrition 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
230000007954 hypoxia Effects 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
238000009434 installation Methods 0.000 description 1
208000028867 ischemia Diseases 0.000 description 1
230000000302 ischemic effect Effects 0.000 description 1
238000002955 isolation Methods 0.000 description 1
QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
230000003137 locomotive effect Effects 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
108010082117 matrigel Proteins 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
239000007769 metal material Substances 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
238000002156 mixing Methods 0.000 description 1
238000010899 nucleation Methods 0.000 description 1
230000009965 odorless effect Effects 0.000 description 1
ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
230000037361 pathway Effects 0.000 description 1
239000008188 pellet Substances 0.000 description 1
210000003200 peritoneal cavity Anatomy 0.000 description 1
239000003208 petroleum Substances 0.000 description 1
JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 1
229910001392 phosphorus oxide Inorganic materials 0.000 description 1
LFGREXWGYUGZLY-UHFFFAOYSA-N phosphoryl Chemical class [P]=O LFGREXWGYUGZLY-UHFFFAOYSA-N 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
229920002492 poly(sulfone) Polymers 0.000 description 1
229920002647 polyamide Polymers 0.000 description 1
229920002857 polybutadiene Polymers 0.000 description 1
229920000139 polyethylene terephthalate Polymers 0.000 description 1
239000005020 polyethylene terephthalate Substances 0.000 description 1
229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
239000002952 polymeric resin Substances 0.000 description 1
239000004926 polymethyl methacrylate Substances 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
150000004804 polysaccharides Chemical class 0.000 description 1
229920002223 polystyrene Polymers 0.000 description 1
229920002635 polyurethane Polymers 0.000 description 1
239000004814 polyurethane Substances 0.000 description 1
238000003825 pressing Methods 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
238000005086 pumping Methods 0.000 description 1
230000005855 radiation Effects 0.000 description 1
238000009877 rendering Methods 0.000 description 1
229920005989 resin Polymers 0.000 description 1
239000011347 resin Substances 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
238000007873 sieving Methods 0.000 description 1
LIVNPJMFVYWSIS-UHFFFAOYSA-N silicon monoxide Chemical class [Si-]#[O+] LIVNPJMFVYWSIS-UHFFFAOYSA-N 0.000 description 1
229910052814 silicon oxide Inorganic materials 0.000 description 1
210000002027 skeletal muscle Anatomy 0.000 description 1
239000002002 slurry Substances 0.000 description 1
VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 description 1
238000003860 storage Methods 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
238000001356 surgical procedure Methods 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
239000000725 suspension Substances 0.000 description 1
229920003002 synthetic resin Polymers 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
239000012815 thermoplastic material Substances 0.000 description 1
229920001187 thermosetting polymer Polymers 0.000 description 1
230000007704 transition Effects 0.000 description 1
239000003981 vehicle Substances 0.000 description 1
210000003462 vein Anatomy 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0004—Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/022—Artificial gland structures using bioreactors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/048—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/145—Hydrogels or hydrocolloids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/146—Porous materials, e.g. foams or sponges
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N5/1007—Arrangements or means for the introduction of sources into the body

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Surgery (AREA)
Biomedical Technology (AREA)
Engineering & Computer Science (AREA)
Transplantation (AREA)
Oral & Maxillofacial Surgery (AREA)
Cardiology (AREA)
Dispersion Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Urology & Nephrology (AREA)
Prostheses (AREA)
Materials For Medical Uses (AREA)
Media Introduction/Drainage Providing Device (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)
Medicinal Preparation (AREA)

NL1003300A 1995-06-07 1996-06-07 Implanteerbare therapeutische inrichting. NL1003300C2 (nl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US48225095A	1995-06-07	1995-06-07
US48225095		1995-06-07

Publications (2)

Publication Number	Publication Date
NL1003300A1 NL1003300A1 (nl)	1996-12-10
NL1003300C2 true NL1003300C2 (nl)	1997-03-20

Family

ID=23915336

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL1003300A NL1003300C2 (nl)	1995-06-07	1996-06-07	Implanteerbare therapeutische inrichting.

Country Status (9)

Country	Link
US (3)	US5913998A (ja)
EP (1)	EP0773753B1 (ja)
JP (1)	JPH10503964A (ja)
AU (1)	AU6251196A (ja)
CA (1)	CA2190628C (ja)
DE (1)	DE69630266T2 (ja)
FR (1)	FR2735032B1 (ja)
NL (1)	NL1003300C2 (ja)
WO (1)	WO1996039993A1 (ja)

Families Citing this family (310)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6331188B1 (en)	1994-08-31	2001-12-18	Gore Enterprise Holdings, Inc.	Exterior supported self-expanding stent-graft
US6015429A (en)	1994-09-08	2000-01-18	Gore Enterprise Holdings, Inc.	Procedures for introducing stents and stent-grafts
WO1996039993A1 (en) *	1995-06-07	1996-12-19	Gore Hybrid Technologies, Inc.	An implantable containment apparatus for a therapeutical device and method for loading and reloading the device therein
JP2000503559A (ja)	1995-12-14	2000-03-28	ゴアエンタープライズホールディングス，インコーポレイティド	ステント移植片を展開する装置並びに方法
US6042605A (en)	1995-12-14	2000-03-28	Gore Enterprose Holdings, Inc.	Kink resistant stent-graft
AU721064B2 (en)	1996-12-20	2000-06-22	Evoqua Water Technologies Llc	Scouring method
US6306491B1 (en) *	1996-12-20	2001-10-23	Gore Enterprise Holdings, Inc.	Respiratory aids
US6352561B1 (en)	1996-12-23	2002-03-05	W. L. Gore & Associates	Implant deployment apparatus
US6551350B1 (en)	1996-12-23	2003-04-22	Gore Enterprise Holdings, Inc.	Kink resistant bifurcated prosthesis
US7657297B2 (en) *	2004-05-03	2010-02-02	Dexcom, Inc.	Implantable analyte sensor
US6001067A (en)	1997-03-04	1999-12-14	Shults; Mark C.	Device and method for determining analyte levels
US7192450B2 (en)	2003-05-21	2007-03-20	Dexcom, Inc.	Porous membranes for use with implantable devices
US8527026B2 (en)	1997-03-04	2013-09-03	Dexcom, Inc.	Device and method for determining analyte levels
US20050033132A1 (en)	1997-03-04	2005-02-10	Shults Mark C.	Analyte measuring device
US6117643A (en) *	1997-11-25	2000-09-12	Ut Battelle, Llc	Bioluminescent bioreporter integrated circuit
US8974386B2 (en)	1998-04-30	2015-03-10	Abbott Diabetes Care Inc.	Analyte monitoring device and methods of use
US8346337B2 (en)	1998-04-30	2013-01-01	Abbott Diabetes Care Inc.	Analyte monitoring device and methods of use
US8465425B2 (en)	1998-04-30	2013-06-18	Abbott Diabetes Care Inc.	Analyte monitoring device and methods of use
US8688188B2 (en)	1998-04-30	2014-04-01	Abbott Diabetes Care Inc.	Analyte monitoring device and methods of use
US6175752B1 (en)	1998-04-30	2001-01-16	Therasense, Inc.	Analyte monitoring device and methods of use
US6949816B2 (en)	2003-04-21	2005-09-27	Motorola, Inc.	Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US9066695B2 (en)	1998-04-30	2015-06-30	Abbott Diabetes Care Inc.	Analyte monitoring device and methods of use
US8480580B2 (en)	1998-04-30	2013-07-09	Abbott Diabetes Care Inc.	Analyte monitoring device and methods of use
US6533766B1 (en) *	1998-07-24	2003-03-18	Therox, Inc.	Coating medical device surfaces for delivering gas-supersaturated fluids
US6432126B1 (en) *	1998-09-30	2002-08-13	C.R. Bard, Inc.	Flexible vascular inducing implants
EP1137451A4 (en) *	1998-12-07	2003-05-21	Std Mfg Inc	IMPLANTABLE VASCULAR ACCESS DEVICE
US8177762B2 (en)	1998-12-07	2012-05-15	C. R. Bard, Inc.	Septum including at least one identifiable feature, access ports including same, and related methods
US6955661B1 (en) *	1999-01-25	2005-10-18	Atrium Medical Corporation	Expandable fluoropolymer device for delivery of therapeutic agents and method of making
US6884427B1 (en) *	1999-02-08	2005-04-26	Aderans Research Institute, Inc.	Filamentary means for introducing agents into tissue of a living host
US6468264B1 (en) *	1999-10-12	2002-10-22	Durect Corporation	Closed exchange system
EP2308522A3 (en) *	1999-11-17	2012-02-29	Boston Scientific Limited	Microfabricated devices for the delivery of molecules into a carrier fluid
US6520997B1 (en)	1999-12-08	2003-02-18	Baxter International Inc.	Porous three dimensional structure
ATE354430T1 (de)	1999-12-08	2007-03-15	Baxter Int	Verfahren zur herstellung einer mikroporösen filtermembran
US20030168396A1 (en) *	1999-12-08	2003-09-11	Jacobson James D.	Monolithic filter body and fabrication technique
US6982058B2 (en) *	1999-12-08	2006-01-03	Baxter International, Inc.	Method for fabricating three dimensional structures
US6479066B1 (en)	1999-12-16	2002-11-12	Rst Implanted Cell Technology, Llc	Device having a microporous membrane lined deformable wall for implanting cell cultures
US6283949B1 (en)	1999-12-27	2001-09-04	Advanced Cardiovascular Systems, Inc.	Refillable implantable drug delivery pump
US6617151B1 (en) *	2000-02-29	2003-09-09	Gore Enterprise Holdings, Inc.	Method of closing a cell containment device with a wet seal
US6810880B1 (en) *	2000-04-10	2004-11-02	Gore Enterprise Holdings, Inc.	Surgical implant system
WO2001080926A2 (en) *	2000-04-26	2001-11-01	Std Manufacturing, Inc.	Implantable hemodialysis access device
JP4017977B2 (ja) *	2000-08-08	2007-12-05	アデランスリサーチインスティテュートインコーポレイテッド	組織工学で処置した毛髪用の台
US6560471B1 (en)	2001-01-02	2003-05-06	Therasense, Inc.	Analyte monitoring device and methods of use
AU2002309528A1 (en)	2001-04-02	2002-10-15	Therasense, Inc.	Blood glucose tracking apparatus and methods
AUPR421501A0 (en)	2001-04-04	2001-05-03	U.S. Filter Wastewater Group, Inc.	Potting method
US20030032874A1 (en)	2001-07-27	2003-02-13	Dexcom, Inc.	Sensor head for use with implantable devices
US6702857B2 (en)	2001-07-27	2004-03-09	Dexcom, Inc.	Membrane for use with implantable devices
AUPR692401A0 (en)	2001-08-09	2001-08-30	U.S. Filter Wastewater Group, Inc.	Method of cleaning membrane modules
US20040068284A1 (en) *	2002-01-29	2004-04-08	Barrows Thomas H.	Method for stimulating hair growth and kit for carrying out said method
WO2003067221A2 (en)	2002-02-08	2003-08-14	Xcyte Therapies, Inc.	Compositions and methods for restoring immune responsiveness in patients with immunological defects
US9282925B2 (en)	2002-02-12	2016-03-15	Dexcom, Inc.	Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8364229B2 (en)	2003-07-25	2013-01-29	Dexcom, Inc.	Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US7247238B2 (en)	2002-02-12	2007-07-24	Siemens Water Technologies Corp.	Poly(ethylene chlorotrifluoroethylene) membranes
US8260393B2 (en)	2003-07-25	2012-09-04	Dexcom, Inc.	Systems and methods for replacing signal data artifacts in a glucose sensor data stream
US9247901B2 (en)	2003-08-22	2016-02-02	Dexcom, Inc.	Systems and methods for replacing signal artifacts in a glucose sensor data stream
US7613491B2 (en)	2002-05-22	2009-11-03	Dexcom, Inc.	Silicone based membranes for use in implantable glucose sensors
US7828728B2 (en)	2003-07-25	2010-11-09	Dexcom, Inc.	Analyte sensor
US8010174B2 (en)	2003-08-22	2011-08-30	Dexcom, Inc.	Systems and methods for replacing signal artifacts in a glucose sensor data stream
US20030176797A1 (en) *	2002-03-12	2003-09-18	Fernando Anzellini	Thrombust; implantable delivery system sensible to self diagnosis of acute myocardial infarction for thrombolysis in the first minutes of chest pain
US20140018880A1 (en)	2002-04-08	2014-01-16	Medtronic Ardian Luxembourg S.A.R.L.	Methods for monopolar renal neuromodulation
US7620451B2 (en)	2005-12-29	2009-11-17	Ardian, Inc.	Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
US8131371B2 (en)	2002-04-08	2012-03-06	Ardian, Inc.	Methods and apparatus for monopolar renal neuromodulation
US6978174B2 (en)	2002-04-08	2005-12-20	Ardian, Inc.	Methods and devices for renal nerve blocking
US8145317B2 (en)	2002-04-08	2012-03-27	Ardian, Inc.	Methods for renal neuromodulation
US8145316B2 (en)	2002-04-08	2012-03-27	Ardian, Inc.	Methods and apparatus for renal neuromodulation
US7853333B2 (en)	2002-04-08	2010-12-14	Ardian, Inc.	Methods and apparatus for multi-vessel renal neuromodulation
US8347891B2 (en)	2002-04-08	2013-01-08	Medtronic Ardian Luxembourg S.A.R.L.	Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US9308043B2 (en)	2002-04-08	2016-04-12	Medtronic Ardian Luxembourg S.A.R.L.	Methods for monopolar renal neuromodulation
US7653438B2 (en)	2002-04-08	2010-01-26	Ardian, Inc.	Methods and apparatus for renal neuromodulation
US20080213331A1 (en)	2002-04-08	2008-09-04	Ardian, Inc.	Methods and devices for renal nerve blocking
US8150520B2 (en)	2002-04-08	2012-04-03	Ardian, Inc.	Methods for catheter-based renal denervation
US7162303B2 (en)	2002-04-08	2007-01-09	Ardian, Inc.	Renal nerve stimulation method and apparatus for treatment of patients
US8150519B2 (en)	2002-04-08	2012-04-03	Ardian, Inc.	Methods and apparatus for bilateral renal neuromodulation
US8774913B2 (en)	2002-04-08	2014-07-08	Medtronic Ardian Luxembourg S.A.R.L.	Methods and apparatus for intravasculary-induced neuromodulation
US9308044B2 (en)	2002-04-08	2016-04-12	Medtronic Ardian Luxembourg S.A.R.L.	Methods for therapeutic renal neuromodulation
US9636174B2 (en)	2002-04-08	2017-05-02	Medtronic Ardian Luxembourg S.A.R.L.	Methods for therapeutic renal neuromodulation
US8774922B2 (en)	2002-04-08	2014-07-08	Medtronic Ardian Luxembourg S.A.R.L.	Catheter apparatuses having expandable balloons for renal neuromodulation and associated systems and methods
US7756583B2 (en)	2002-04-08	2010-07-13	Ardian, Inc.	Methods and apparatus for intravascularly-induced neuromodulation
US20070129761A1 (en)	2002-04-08	2007-06-07	Ardian, Inc.	Methods for treating heart arrhythmia
US7617005B2 (en)	2002-04-08	2009-11-10	Ardian, Inc.	Methods and apparatus for thermally-induced renal neuromodulation
US20070135875A1 (en)	2002-04-08	2007-06-14	Ardian, Inc.	Methods and apparatus for thermally-induced renal neuromodulation
GB2389791B (en) *	2002-04-30	2006-12-13	Steven Gill	Implantable drug delivery pump
US7226978B2 (en)	2002-05-22	2007-06-05	Dexcom, Inc.	Techniques to improve polyurethane membranes for implantable glucose sensors
US6568177B1 (en) *	2002-06-04	2003-05-27	Ford Global Technologies, Llc	Method for rapid catalyst heating
AUPS300602A0 (en)	2002-06-18	2002-07-11	U.S. Filter Wastewater Group, Inc.	Methods of minimising the effect of integrity loss in hollow fibre membrane modules
ES2422193T3 (es)	2002-06-28	2013-09-09	Life Technologies Corp	Métodos para restaurar el repertorio inmune en pacientes con defectos inmunológicos relacionados con la autoinmunidad y trasplante de órganos o de células madre hematopoyéticas
US7938966B2 (en)	2002-10-10	2011-05-10	Siemens Water Technologies Corp.	Backwash method
AU2002953111A0 (en)	2002-12-05	2002-12-19	U. S. Filter Wastewater Group, Inc.	Mixing chamber
US7134999B2 (en) *	2003-04-04	2006-11-14	Dexcom, Inc.	Optimized sensor geometry for an implantable glucose sensor
US20040220534A1 (en) *	2003-04-29	2004-11-04	Martens Paul W.	Medical device with antimicrobial layer
TW200502391A (en) *	2003-05-08	2005-01-16	Xcyte Therapies Inc	Generation and isolation of antigen-specific t cells
US7875293B2 (en)	2003-05-21	2011-01-25	Dexcom, Inc.	Biointerface membranes incorporating bioactive agents
US7761130B2 (en)	2003-07-25	2010-07-20	Dexcom, Inc.	Dual electrode system for a continuous analyte sensor
US8282549B2 (en)	2003-12-09	2012-10-09	Dexcom, Inc.	Signal processing for continuous analyte sensor
EP1648298A4 (en)	2003-07-25	2010-01-13	Dexcom Inc	OXYGEN-IMPROVED MEMBRANE SYSTEMS FOR IMPLANTABLE DEVICES
US9763609B2 (en)	2003-07-25	2017-09-19	Dexcom, Inc.	Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US8423113B2 (en)	2003-07-25	2013-04-16	Dexcom, Inc.	Systems and methods for processing sensor data
US7519408B2 (en)	2003-11-19	2009-04-14	Dexcom, Inc.	Integrated receiver for continuous analyte sensor
US20100168657A1 (en)	2003-08-01	2010-07-01	Dexcom, Inc.	System and methods for processing analyte sensor data
US8761856B2 (en)	2003-08-01	2014-06-24	Dexcom, Inc.	System and methods for processing analyte sensor data
US8369919B2 (en)	2003-08-01	2013-02-05	Dexcom, Inc.	Systems and methods for processing sensor data
US8160669B2 (en)	2003-08-01	2012-04-17	Dexcom, Inc.	Transcutaneous analyte sensor
US8275437B2 (en)	2003-08-01	2012-09-25	Dexcom, Inc.	Transcutaneous analyte sensor
US7774145B2 (en)	2003-08-01	2010-08-10	Dexcom, Inc.	Transcutaneous analyte sensor
US7986986B2 (en)	2003-08-01	2011-07-26	Dexcom, Inc.	System and methods for processing analyte sensor data
US7591801B2 (en)	2004-02-26	2009-09-22	Dexcom, Inc.	Integrated delivery device for continuous glucose sensor
US8886273B2 (en)	2003-08-01	2014-11-11	Dexcom, Inc.	Analyte sensor
US20190357827A1 (en)	2003-08-01	2019-11-28	Dexcom, Inc.	Analyte sensor
US8060173B2 (en)	2003-08-01	2011-11-15	Dexcom, Inc.	System and methods for processing analyte sensor data
US7920906B2 (en)	2005-03-10	2011-04-05	Dexcom, Inc.	System and methods for processing analyte sensor data for sensor calibration
US20140121989A1 (en)	2003-08-22	2014-05-01	Dexcom, Inc.	Systems and methods for processing analyte sensor data
US8268176B2 (en)	2003-08-29	2012-09-18	Siemens Industry, Inc.	Backwash
SE526959C2 (sv) *	2003-10-02	2005-11-29	Tikomed Ab	Bioartificellt implantat innefattande en semipermeabel barriär samt förfarande för reducering av risken för bildning av bindrväv vid implantatet efter implantering genom att barriären förses med en permeabel beläggning av bioaktiv metall
AU2004289373B2 (en)	2003-11-14	2010-07-29	Evoqua Water Technologies Llc	Improved module cleaning method
US9247900B2 (en)	2004-07-13	2016-02-02	Dexcom, Inc.	Analyte sensor
US11633133B2 (en)	2003-12-05	2023-04-25	Dexcom, Inc.	Dual electrode system for a continuous analyte sensor
US8532730B2 (en)	2006-10-04	2013-09-10	Dexcom, Inc.	Analyte sensor
US8364231B2 (en)	2006-10-04	2013-01-29	Dexcom, Inc.	Analyte sensor
WO2005057168A2 (en)	2003-12-05	2005-06-23	Dexcom, Inc.	Calibration techniques for a continuous analyte sensor
US8423114B2 (en)	2006-10-04	2013-04-16	Dexcom, Inc.	Dual electrode system for a continuous analyte sensor
US8287453B2 (en)	2003-12-05	2012-10-16	Dexcom, Inc.	Analyte sensor
JP5132153B2 (ja) *	2003-12-30	2013-01-30	ボストンサイエンティフィックリミテッド	フッ素重合体生成物の一軸延伸法
US7637868B2 (en)	2004-01-12	2009-12-29	Dexcom, Inc.	Composite material for implantable device
US7803178B2 (en) *	2004-01-30	2010-09-28	Trivascular, Inc.	Inflatable porous implants and methods for drug delivery
US7364592B2 (en) *	2004-02-12	2008-04-29	Dexcom, Inc.	Biointerface membrane with macro-and micro-architecture
WO2009048462A1 (en)	2007-10-09	2009-04-16	Dexcom, Inc.	Integrated insulin delivery system with continuous glucose sensor
US8808228B2 (en)	2004-02-26	2014-08-19	Dexcom, Inc.	Integrated medicament delivery device for use with continuous analyte sensor
US7597885B2 (en) *	2004-03-26	2009-10-06	Aderans Research Institute, Inc.	Tissue engineered biomimetic hair follicle graft
WO2005092799A1 (en)	2004-03-26	2005-10-06	U.S. Filter Wastewater Group, Inc.	Process and apparatus for purifying impure water using microfiltration or ultrafiltration in combination with reverse osmosis
US8377110B2 (en) *	2004-04-08	2013-02-19	Endologix, Inc.	Endolumenal vascular prosthesis with neointima inhibiting polymeric sleeve
AU2005240524C1 (en)	2004-04-22	2009-12-24	Evoqua Water Technologies Llc	Filtration apparatus comprising a membrane bioreactor and a treatment vessel for digesting organic materials
US8277713B2 (en)	2004-05-03	2012-10-02	Dexcom, Inc.	Implantable analyte sensor
US8792955B2 (en)	2004-05-03	2014-07-29	Dexcom, Inc.	Transcutaneous analyte sensor
US20050245799A1 (en) *	2004-05-03	2005-11-03	Dexcom, Inc.	Implantable analyte sensor
US7968250B2 (en) *	2004-06-25	2011-06-28	Ultracell Corporation	Fuel cartridge connectivity
US8452368B2 (en)	2004-07-13	2013-05-28	Dexcom, Inc.	Transcutaneous analyte sensor
US8886272B2 (en)	2004-07-13	2014-11-11	Dexcom, Inc.	Analyte sensor
US7905833B2 (en)	2004-07-13	2011-03-15	Dexcom, Inc.	Transcutaneous analyte sensor
US20070045902A1 (en)	2004-07-13	2007-03-01	Brauker James H	Analyte sensor
US7811266B2 (en) *	2004-07-13	2010-10-12	Std Med, Inc.	Volume reducing reservoir insert for an infusion port
US8989833B2 (en)	2004-07-13	2015-03-24	Dexcom, Inc.	Transcutaneous analyte sensor
US8565848B2 (en)	2004-07-13	2013-10-22	Dexcom, Inc.	Transcutaneous analyte sensor
US7783333B2 (en)	2004-07-13	2010-08-24	Dexcom, Inc.	Transcutaneous medical device with variable stiffness
EP3417895A1 (en)	2004-07-28	2018-12-26	Medtronic Ardian Luxembourg S.à.r.l.	Methods and devices for renal nerve blocking
AR050212A1 (es) *	2004-08-13	2006-10-04	Aderans Res Inst Inc	Organogenesis a partir de celulas disociadas
JP4958779B2 (ja)	2004-08-20	2012-06-20	シーメンス・ウォーター・テクノロジーズ・コーポレイション	正方形のｍｂｒマニホールド・システム
WO2006026814A1 (en)	2004-09-07	2006-03-16	Siemens Water Technologies Corp.	Reduction of backwash liquid waste
JP4896025B2 (ja)	2004-09-14	2012-03-14	シーメンス・ウォーター・テクノロジーズ・コーポレイション	膜モジュールから固形分を除去するための方法および装置
JP4954880B2 (ja)	2004-09-15	2012-06-20	シーメンス・ウォーター・テクノロジーズ・コーポレーション	連続的に変化する通気
US7591950B2 (en)	2004-11-02	2009-09-22	Siemens Water Technologies Corp.	Submerged cross-flow filtration
US7937143B2 (en)	2004-11-02	2011-05-03	Ardian, Inc.	Methods and apparatus for inducing controlled renal neuromodulation
US9788978B2 (en) *	2004-12-20	2017-10-17	Nicholas A. Rojo	Implantable systems and stents containing cells for therapeutic uses
WO2006066319A1 (en)	2004-12-24	2006-06-29	Siemens Water Technologies Corp.	Cleaning in membrane filtration systems
EP1838422A4 (en)	2004-12-24	2009-09-02	Siemens Water Tech Corp	EASY GAS FLUSHING PROCESS AND APPROPRIATE DEVICE
US9320831B2 (en) *	2005-03-04	2016-04-26	W. L. Gore & Associates, Inc.	Polymer shrink tubes and novel uses therefor
US8029482B2 (en)	2005-03-04	2011-10-04	C. R. Bard, Inc.	Systems and methods for radiographically identifying an access port
US7947022B2 (en)	2005-03-04	2011-05-24	C. R. Bard, Inc.	Access port identification systems and methods
US9474888B2 (en)	2005-03-04	2016-10-25	C. R. Bard, Inc.	Implantable access port including a sandwiched radiopaque insert
US7785302B2 (en)	2005-03-04	2010-08-31	C. R. Bard, Inc.	Access port identification systems and methods
US8744546B2 (en)	2005-05-05	2014-06-03	Dexcom, Inc.	Cellulosic-based resistance domain for an analyte sensor
US20060233990A1 (en)	2005-04-13	2006-10-19	Trivascular, Inc.	PTFE layers and methods of manufacturing
US20060233991A1 (en)	2005-04-13	2006-10-19	Trivascular, Inc.	PTFE layers and methods of manufacturing
EP1874393B1 (en)	2005-04-27	2017-09-06	C.R.Bard, Inc.	Infusion apparatuses
DE602006019587D1 (de)	2005-04-27	2011-02-24	Bard Inc C R	Spritzenpumpesystem zur Injektion von Kontrastmittel in einer intravenösen Leitung
US10307581B2 (en)	2005-04-27	2019-06-04	C. R. Bard, Inc.	Reinforced septum for an implantable medical device
CN101184548B (zh)	2005-04-29	2011-10-05	西门子水技术公司	用于膜滤器的化学清洗剂
JP2009504399A (ja)	2005-08-22	2009-02-05	シーメンス・ウォーター・テクノロジーズ・コーポレーション	管状マニホールドを使用して逆洗を最小化する水濾過のためのアセンブリ
KR100756411B1 (ko) *	2005-09-08	2007-09-10	삼성전자주식회사	열압착 공구 및 이를 포함한 열압착 장치
US20070078416A1 (en) *	2005-10-04	2007-04-05	Kenneth Eliasen	Two-piece inline vascular access portal
WO2007044415A2 (en)	2005-10-05	2007-04-19	Siemens Water Technologies Corp.	Method and apparatus for treating wastewater
WO2007044345A2 (en)	2005-10-05	2007-04-19	Siemens Water Technologies Corp.	Method and apparatus for treating wastewater
JP5153638B2 (ja) *	2005-10-17	2013-02-27	アデランスリサーチインスティテュートインコーポレイテッド	毛包前駆細胞を皮膚に送達する方法
CN101511303A (zh) *	2005-11-21	2009-08-19	尼卡斯特有限公司	用于细胞移植的装置和方法
TW200803877A (en) *	2005-11-22	2008-01-16	Aderans Res Inst Inc	Hair grafts derived from plucked hair
WO2007062386A2 (en) *	2005-11-22	2007-05-31	Aderans Research Institute, Inc.	Hair follicle graft from tissue engineered skin
US8197441B2 (en) *	2005-12-06	2012-06-12	Abbott Cardiovascular Systems Inc.	Catheter mounted automatic vessel occlusion and fluid dispersion devices
US7455765B2 (en)	2006-01-25	2008-11-25	Siemens Water Technologies Corp.	Wastewater treatment system and method
WO2007102842A2 (en)	2006-03-09	2007-09-13	Dexcom, Inc.	Systems and methods for processing analyte sensor data
WO2007143225A2 (en)	2006-06-07	2007-12-13	Abbott Diabetes Care, Inc.	Analyte monitoring system and method
US8293098B2 (en)	2006-10-24	2012-10-23	Siemens Industry, Inc.	Infiltration/inflow control for membrane bioreactor
US9642986B2 (en)	2006-11-08	2017-05-09	C. R. Bard, Inc.	Resource information key for an insertable medical device
US9265912B2 (en)	2006-11-08	2016-02-23	C. R. Bard, Inc.	Indicia informative of characteristics of insertable medical devices
US8734730B2 (en) *	2007-03-30	2014-05-27	Covidien Lp	Surgical instrument debris collection system
WO2008123972A1 (en)	2007-04-02	2008-10-16	Siemens Water Technologies Corp.	Improved infiltration/inflow control for membrane bioreactor
US9764288B2 (en)	2007-04-04	2017-09-19	Evoqua Water Technologies Llc	Membrane module protection
US20200037875A1 (en)	2007-05-18	2020-02-06	Dexcom, Inc.	Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
AU2008263139B2 (en)	2007-05-29	2011-08-25	Evoqua Water Technologies Llc	Membrane cleaning with pulsed airlift pump
US20080306444A1 (en)	2007-06-08	2008-12-11	Dexcom, Inc.	Integrated medicament delivery device for use with continuous analyte sensor
US7985537B2 (en) *	2007-06-12	2011-07-26	Aderans Research Institute, Inc.	Methods for determining the hair follicle inductive properties of a composition
PT3269417T (pt)	2007-06-20	2025-11-05	Medical Components Inc	Dispositivo de acesso implantável com indicações moldadas e/ou radiopacas
US9610432B2 (en)	2007-07-19	2017-04-04	Innovative Medical Devices, Llc	Venous access port assembly with X-ray discernable indicia
ES2650800T5 (en)	2007-07-19	2025-05-05	Medical Components Inc	Venous access port assembly with x-ray discernable indicia
BRPI0721966A2 (pt) *	2007-10-11	2014-06-10	Pang Ah San	Dispositivo de alimentação por tubo
US8417312B2 (en)	2007-10-25	2013-04-09	Dexcom, Inc.	Systems and methods for processing sensor data
US9579496B2 (en)	2007-11-07	2017-02-28	C. R. Bard, Inc.	Radiopaque and septum-based indicators for a multi-lumen implantable port
US20090196854A1 (en) *	2008-02-04	2009-08-06	Kytos Biosystems S.A.	Methods and compositions for use of crl 5803 cells for expression of biotherapeutics and encapsulated cell-based delivery
US11730407B2 (en)	2008-03-28	2023-08-22	Dexcom, Inc.	Polymer membranes for continuous analyte sensors
US8583204B2 (en)	2008-03-28	2013-11-12	Dexcom, Inc.	Polymer membranes for continuous analyte sensors
US8682408B2 (en)	2008-03-28	2014-03-25	Dexcom, Inc.	Polymer membranes for continuous analyte sensors
JP2013500144A (ja)	2008-07-24	2013-01-07	シーメンスインダストリーインコーポレイテッド	濾過システムにおける濾過膜モジュールアレイに対して構造的支持を施すための方法および濾過システム
US8105308B2 (en) *	2008-08-02	2012-01-31	Ghodsian Laboratories, Inc.	Permanent umbilical hollow tube
NZ591259A (en)	2008-08-20	2013-02-22	Siemens Industry Inc	A hollow membrane filter backwash system using gas pressurised at at least two pressures feed from the down stream side to push water through the filter to clean it
US20100080784A1 (en) *	2008-09-12	2010-04-01	Torrey Pines Institute For Molecular Studies	Methods for treating cachexia and lymphopenia
EP4549933A3 (en)	2008-09-19	2025-05-21	DexCom, Inc.	Particle-containing membrane and particulate electrode for analyte sensors
EP3978066B1 (en)	2008-10-31	2025-01-15	C. R. Bard, Inc.	Systems for identifying an access port
JP4944864B2 (ja) *	2008-11-04	2012-06-06	日東電工株式会社	ポリテトラフルオロエチレン多孔質膜およびその製造方法ならびに防水通気フィルタ
US8932271B2 (en)	2008-11-13	2015-01-13	C. R. Bard, Inc.	Implantable medical devices including septum-based indicators
US11890443B2 (en)	2008-11-13	2024-02-06	C. R. Bard, Inc.	Implantable medical devices including septum-based indicators
JP2012508584A (ja) *	2008-11-14	2012-04-12	ヴィアサイト，インコーポレイテッド	ヒト多能性幹細胞由来膵臓細胞のカプセル化
US8652129B2 (en)	2008-12-31	2014-02-18	Medtronic Ardian Luxembourg S.A.R.L.	Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation
EP2410910A4 (en) *	2009-03-27	2014-10-15	Dexcom Inc	METHODS AND SYSTEMS FOR PROMOTING GLUCOSE MANAGEMENT
US8627867B2 (en) *	2009-04-21	2014-01-14	Bae Systems Information And Electronic Systems Integration Inc.	System and method for microelectronics lamination press
AU2010101488B4 (en)	2009-06-11	2013-05-02	Evoqua Water Technologies Llc	Methods for cleaning a porous polymeric membrane and a kit for cleaning a porous polymeric membrane
WO2011005847A1 (en)	2009-07-07	2011-01-13	C. R. Bard, Inc.	Extensible internal bolster for a medical device
PL2470228T3 (pl)	2009-08-28	2018-03-30	Sernova Corporation	Sposoby i urządzenia do przeszczepiania komórek
US9079004B2 (en)	2009-11-17	2015-07-14	C. R. Bard, Inc.	Overmolded access port including anchoring and identification features
US8377034B2 (en)	2009-12-04	2013-02-19	Std Med, Inc.	Vascular access port
ES2738898T3 (es)	2010-04-30	2020-01-27	Evoqua Water Tech Llc	Dispositivo de distribución de flujo de fluido
US9023095B2 (en) *	2010-05-27	2015-05-05	Idev Technologies, Inc.	Stent delivery system with pusher assembly
US9475709B2 (en)	2010-08-25	2016-10-25	Lockheed Martin Corporation	Perforated graphene deionization or desalination
AU2011305377B2 (en)	2010-09-24	2014-11-20	Evoqua Water Technologies Llc	Fluid control manifold for membrane filtration system
CN103313671B (zh)	2010-10-25	2017-06-06	美敦力Af卢森堡有限责任公司	用于神经调节治疗的估算及反馈的装置、系统及方法
USD676955S1 (en)	2010-12-30	2013-02-26	C. R. Bard, Inc.	Implantable access port
USD682416S1 (en)	2010-12-30	2013-05-14	C. R. Bard, Inc.	Implantable access port
US9433557B2 (en) *	2011-02-21	2016-09-06	Viacyte, Inc.	Loading system for an encapsulation device
EP3575796B1 (en)	2011-04-15	2020-11-11	DexCom, Inc.	Advanced analyte sensor calibration and error detection
CN103958034B (zh)	2011-09-30	2017-03-22	伊沃夸水处理技术有限责任公司	隔离阀
CA2850309C (en)	2011-09-30	2020-01-07	Evoqua Water Technologies Llc	Improved manifold arrangement
EP3696262A1 (en)	2011-11-23	2020-08-19	The Trustees Of The University Of Pennsylvania	Use of pdl1 expressing cells to convert t cells into regulatory t cells
JP6195856B2 (ja)	2012-03-08	2017-09-13	メドトロニックアーディアンルクセンブルクソシエテアレスポンサビリテリミテ	神経調節装置に関するバイオマーカーのサンプリングならびに関連システムおよび方法
AU2013230781B2 (en)	2012-03-08	2015-12-03	Medtronic Af Luxembourg S.A.R.L.	Ovarian neuromodulation and associated systems and methods
US9834809B2 (en)	2014-02-28	2017-12-05	Lockheed Martin Corporation	Syringe for obtaining nano-sized materials for selective assays and related methods of use
US9744617B2 (en)	2014-01-31	2017-08-29	Lockheed Martin Corporation	Methods for perforating multi-layer graphene through ion bombardment
US9844757B2 (en)	2014-03-12	2017-12-19	Lockheed Martin Corporation	Separation membranes formed from perforated graphene and methods for use thereof
US10376845B2 (en)	2016-04-14	2019-08-13	Lockheed Martin Corporation	Membranes with tunable selectivity
US10653824B2 (en)	2012-05-25	2020-05-19	Lockheed Martin Corporation	Two-dimensional materials and uses thereof
US9533261B2 (en)	2012-06-28	2017-01-03	Evoqua Water Technologies Llc	Potting method
AU2013231145B2 (en)	2012-09-26	2017-08-17	Evoqua Water Technologies Llc	Membrane potting methods
CN104684631A (zh)	2012-09-26	2015-06-03	伊沃夸水处理技术有限责任公司	膜固定设备
EP2900356A1 (en)	2012-09-27	2015-08-05	Evoqua Water Technologies LLC	Gas scouring apparatus for immersed membranes
US20140110296A1 (en)	2012-10-19	2014-04-24	Medtronic Ardian Luxembourg S.A.R.L.	Packaging for Catheter Treatment Devices and Associated Devices, Systems, and Methods
EP3342391B1 (en)	2013-01-23	2025-01-22	C. R. Bard, Inc.	Low-profile access port
US11464960B2 (en)	2013-01-23	2022-10-11	C. R. Bard, Inc.	Low-profile single and dual vascular access device
US11420033B2 (en)	2013-01-23	2022-08-23	C. R. Bard, Inc.	Low-profile single and dual vascular access device
AU2014225352B2 (en) *	2013-03-07	2017-02-09	Viacyte, Inc.	3-dimensional large capacity cell encapsulation device assembly
TW201504140A (zh)	2013-03-12	2015-02-01	Lockheed Corp	形成具有均勻孔尺寸之多孔石墨烯之方法
WO2014152832A1 (en)	2013-03-14	2014-09-25	Immusoft Corporation	Methods for in vitro memory b cell differentiation and transduction with vsv-g pseudotyped viral vectors
US9572918B2 (en)	2013-06-21	2017-02-21	Lockheed Martin Corporation	Graphene-based filter for isolating a substance from blood
EP3052221B1 (en)	2013-10-02	2022-12-14	Rohm & Haas Electronic Materials Singapore Pte. Ltd	Device for repairing a membrane filtration module
CN106029596A (zh)	2014-01-31	2016-10-12	洛克希德马丁公司	采用多孔非牺牲性支撑层的二维材料形成复合结构的方法
CN105940479A (zh)	2014-01-31	2016-09-14	洛克希德马丁公司	使用宽离子场穿孔二维材料
US9980766B1 (en)	2014-03-28	2018-05-29	Medtronic Ardian Luxembourg S.A.R.L.	Methods and systems for renal neuromodulation
US10194980B1 (en)	2014-03-28	2019-02-05	Medtronic Ardian Luxembourg S.A.R.L.	Methods for catheter-based renal neuromodulation
US10194979B1 (en)	2014-03-28	2019-02-05	Medtronic Ardian Luxembourg S.A.R.L.	Methods for catheter-based renal neuromodulation
US10369345B2 (en)	2014-03-31	2019-08-06	Versago Vascular Access, Inc.	Medical access port, systems and methods of use thereof
US9764124B2 (en)	2014-03-31	2017-09-19	Versago Vascular Access, Inc.	Vascular access port
AU2015240568B2 (en)	2014-04-03	2019-08-22	Versago Vascular Access, Inc.	Devices and methods for installation and removal of a needle tip of a needle
US10912933B2 (en)	2014-08-19	2021-02-09	The Regents Of The University Of California	Implants for localized drug delivery and methods of use thereof
JP2017534311A (ja)	2014-09-02	2017-11-24	ロッキード・マーチン・コーポレーション	二次元膜材料をベースとする血液透析膜および血液濾過膜、ならびにそれを用いた方法
EP3206567A1 (en)	2014-10-13	2017-08-23	Glusense, Ltd.	Analyte-sensing device
ES2910227T3 (es)	2014-10-31	2022-05-12	Univ Pennsylvania	Composición y métodos para la estimulación y expansión de células T
US20170335331A1 (en)	2014-10-31	2017-11-23	The Trustees Of The University Of Pennsylvania	Altering Gene Expression in CART Cells and Uses Thereof
CA2964958A1 (en)	2014-10-31	2016-05-06	The Trustees Of The University Of Pennsylvania	Methods and compositions for modified t cells
JP6673919B2 (ja)	2014-12-18	2020-03-25	ヴェルサゴヴァスキュラーアクセスインコーポレイテッド	埋め込み式アクセスポート用のカテーテルの除去及び置換のためのデバイス、システム、及び方法
US11154687B2 (en)	2014-12-18	2021-10-26	Versago Vascular Access, Inc.	Catheter patency systems and methods
DK3234107T3 (da)	2014-12-19	2022-10-17	Immusoft Corp	B-celler til in vivo-levering af terapeutiske midler
US10828353B2 (en)	2015-01-31	2020-11-10	The Trustees Of The University Of Pennsylvania	Compositions and methods for T cell delivery of therapeutic molecules
WO2016133779A1 (en)	2015-02-16	2016-08-25	The Trustees Of The University Of Pennsylvania	A fully-human t cell receptor specific for the 369-377 epitope derived from the her2/neu (erbb2) receptor protein
WO2017011068A1 (en)	2015-07-14	2017-01-19	Evoqua Water Technologies Llc	Aeration device for filtration system
EP3322460B1 (en)	2015-07-14	2022-09-07	Versago Vascular Access, Inc.	Medical access ports and transfer devices
JP2018528144A (ja)	2015-08-05	2018-09-27	ロッキード・マーチン・コーポレーション	グラフェン系材料の穿孔可能なシート
WO2017023377A1 (en)	2015-08-06	2017-02-09	Lockheed Martin Corporation	Nanoparticle modification and perforation of graphene
EP3442697A4 (en)	2016-04-14	2020-03-18	Lockheed Martin Corporation	SELECTIVE INTERFACE REDUCTION OF GRAPH DEFECTS
EP3442739A4 (en)	2016-04-14	2020-03-04	Lockheed Martin Corporation	PROCESS FOR PROCESSING GRAPHENE SHEETS FOR LARGE SCALE TRANSFER USING A FREE FLOATING PROCESS
KR20180133430A (ko)	2016-04-14	2018-12-14	록히드 마틴 코포레이션	결함 형성 또는 힐링의 인 시츄 모니터링 및 제어를 위한 방법
WO2017180134A1 (en)	2016-04-14	2017-10-19	Lockheed Martin Corporation	Methods for in vivo and in vitro use of graphene and other two-dimensional materials
EP3442786A4 (en)	2016-04-14	2020-03-18	Lockheed Martin Corporation	TWO-DIMENSIONAL MEMBRANE STRUCTURES HAVING FLOW PASSAGES
EP3445872A1 (en)	2016-04-20	2019-02-27	Glusense Ltd.	Fret-based glucose-detection molecules
KR20230037059A (ko)	2016-11-03	2023-03-15	아리조나 보드 오브 리전츠 온 비해프 오브 더 유니버시티 오브 아리조나	외부 산소 전달을 수반 또는 비-수반하는 산소 센서가 구비된 캡슐화 장치 시스템
SG10202104562TA (en)	2016-11-03	2021-06-29	Univ Arizona	Stacked tissue encapsulation device systems with or without oxygen delivery
US11746318B2 (en)	2016-11-03	2023-09-05	Arizona Board Of Regents On Behalf Of The University Of Arizona	Methods and systems for real-time assessment of cells in encapsulation devices pre-and post-transplantation
US10849731B2 (en)	2016-11-08	2020-12-01	W. L. Gore & Associates, Inc.	Cell encapsulation devices containing structural spacers
US11707611B2 (en)	2016-11-08	2023-07-25	W. L. Gore & Associates, Inc.	Implantable apparatus for retention of biological moieties
US11338068B2 (en) *	2016-11-08	2022-05-24	W. L. Gore & Associates, Inc.	Two-part implantable therapy delivery device
US11052230B2 (en) *	2016-11-08	2021-07-06	W. L. Gore & Associates, Inc.	Implantable encapsulation devices
CA3042495A1 (en) *	2016-11-10	2018-05-17	Viacyte, Inc.	Pdx1 pancreatic endoderm cells in cell delivery devices and methods thereof
USD870264S1 (en)	2017-09-06	2019-12-17	C. R. Bard, Inc.	Implantable apheresis port
US11331022B2 (en)	2017-10-24	2022-05-17	Dexcom, Inc.	Pre-connected analyte sensors
US11382540B2 (en)	2017-10-24	2022-07-12	Dexcom, Inc.	Pre-connected analyte sensors
WO2019126306A1 (en)	2017-12-21	2019-06-27	Versago Vascular Access, Inc.	Medical access ports, transfer devices and methods of use thereof
EP3501559B1 (en)	2017-12-22	2021-11-17	BIOTRONIK SE & Co. KG	System with an intracardiac implant and a cover for the implant
US12247060B2 (en)	2018-01-09	2025-03-11	Marengo Therapeutics, Inc.	Calreticulin binding constructs and engineered T cells for the treatment of diseases
WO2019157421A1 (en)	2018-02-09	2019-08-15	W. L. Gore & Associates, Inc.	Implantable access chamber and associated methods of use
EP3765517A1 (en)	2018-03-14	2021-01-20	Elstar Therapeutics, Inc.	Multifunctional molecules that bind to calreticulin and uses thereof
EP3765601A1 (en)	2018-03-16	2021-01-20	Immusoft Corporation	B cells genetically engineered to secrete follistatin and methods of using the same to treat follistatin-related diseases, conditions, disorders and to enhance muscle growth and strength
CA3105448A1 (en)	2018-07-03	2020-01-09	Elstar Therapeutics, Inc.	Anti-tcr antibody molecules and uses thereof
JP2022501439A (ja) *	2018-09-24	2022-01-06	プロキオン・テクノロジーズ・リミテッド・ライアビリティ・カンパニーProcyon Technologies Llc	植込み医療装置と血管形成膜のための方法及びシステム
CN119039441A (zh)	2019-02-21	2024-11-29	马伦戈治疗公司	与nkp30结合的抗体分子及其用途
GB2599228B (en)	2019-02-21	2024-02-07	Marengo Therapeutics Inc	Multifunctional molecules that bind to T cell related cancer cells and uses thereof
WO2021061940A1 (en)	2019-09-27	2021-04-01	Isla Technologies, Inc.	Bioartificial pancreas
AU2020416273A1 (en)	2020-01-03	2022-07-28	Marengo Therapeutics, Inc.	Anti-TCR antibody molecules and uses thereof
US11338119B2 (en)	2020-03-20	2022-05-24	The Regents Of The University Of California	Implantable drug delivery devices for localized drug delivery
CN115515657A (zh)	2020-03-20	2022-12-23	加利福尼亚大学董事会	用于局部药物递送的可植入药物递送设备
US11173291B2 (en)	2020-03-20	2021-11-16	The Regents Of The University Of California	Implantable drug delivery devices for localized drug delivery
US11344526B2 (en)	2020-03-20	2022-05-31	The Regents Of The University Of California	Implantable drug delivery devices for localized drug delivery
WO2022094380A1 (en)	2020-10-30	2022-05-05	Arizona Board Of Regents On Behalf Of The University Of Arizona	Methods and systems for encapsulation devices for housing cells and agents
WO2022175369A1 (en)	2021-02-19	2022-08-25	F. Hoffmann-La Roche Ag	Means and methods for implanting cells secreting a therapeutic compound
CN120359112A (zh) *	2022-12-16	2025-07-22	W.L.戈尔及同仁股份有限公司	膨胀聚乙烯的选择性致密化
WO2025096730A1 (en)	2023-11-01	2025-05-08	University Of Virginia Patent Foundation	Novel autoregulated car t cells and uses thereof
WO2025106856A1 (en)	2023-11-15	2025-05-22	Immusoft Corporation	Migratory modified differentiated b cells for cancer therapy
WO2025147573A2 (en)	2024-01-05	2025-07-10	Immusoft Corporation	Glp-1 expressing modified b cells for the treatment of metabolic disease

Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4378016A (en) *	1981-07-15	1983-03-29	Biotek, Inc.	Artificial endocrine gland containing hormone-producing cells
EP0107222A1 (fr) *	1982-09-24	1984-05-02	Jean-Bernard Professeur Buchs	Prothèse pour organe artificiel hybride
US4479796A (en) *	1982-11-15	1984-10-30	Medtronic, Inc.	Self-regenerating drug administration device
WO1993000127A1 (en) *	1991-06-28	1993-01-07	Brown University Research Foundation	Neural implant system
WO1993000128A1 (en) *	1991-06-28	1993-01-07	Brown University Research Foundation	Renewable neural implant device and method

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1553554A (en) *	1922-08-05	1925-09-15	Paramount Rubber Company Cons	Method of making hollow rubber articles
US1649734A (en) *	1923-04-16	1927-11-15	Paramount Rubber Cons Inc	Method of making inflated balls
US2364029A (en) *	1941-10-23	1944-11-28	Jean E L Ryan	Method and apparatus for manufacture of hollow rubber articles
US3468096A (en) *	1966-02-08	1969-09-23	Procter & Gamble	Method of interposing a washing compound between superposed layers of nonwoven fibrous material and sealing said layers
CA962021A (en) *	1970-05-21	1975-02-04	Robert W. Gore	Porous products and process therefor
US4810868A (en) *	1985-08-06	1989-03-07	Drexler Technology Corporation	Frasable optical wallet-size data card
US4402694A (en) *	1981-07-16	1983-09-06	Biotek, Inc.	Body cavity access device containing a hormone source
US4792373A (en) *	1985-06-18	1988-12-20	Baxter Travenol Laboratories, Inc.	Heat sealing apparatus
US4632842A (en) *	1985-06-20	1986-12-30	Atrium Medical Corporation	Glow discharge process for producing implantable devices
US4718907A (en) *	1985-06-20	1988-01-12	Atrium Medical Corporation	Vascular prosthesis having fluorinated coating with varying F/C ratio
EP0241838B1 (en) *	1986-04-07	1992-04-15	Agency Of Industrial Science And Technology	Antithrombogenic material
US5061276A (en) *	1987-04-28	1991-10-29	Baxter International Inc.	Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation
US5026365A (en) *	1987-04-29	1991-06-25	The University Of Massachusetts	Method and apparatus for therapeutically treating immunological disorders and disease states
US5071506A (en) *	1987-10-09	1991-12-10	Thiokol Corporation	Equipment for making composite tubes including an inflatable heated bladder and a composite mold having a negative coefficient of thermal expansion
US5106627A (en) *	1987-11-17	1992-04-21	Brown University Research Foundation	Neurological therapy devices
US5487739A (en) *	1987-11-17	1996-01-30	Brown University Research Foundation	Implantable therapy systems and methods
US5182111A (en) *	1987-11-17	1993-01-26	Boston University Research Foundation	In vivo delivery of active factors by co-cultured cell implants
US5156844A (en) *	1987-11-17	1992-10-20	Brown University Research Foundation	Neurological therapy system
US5871472A (en) *	1987-11-17	1999-02-16	Brown University Research Foundation	Planting devices for the focal release of neuroinhibitory compounds
JPH03503167A (ja) *	1988-02-24	1991-07-18	アメリカンナショナルレッドクロス	部位指定血管形成素子とその使用法
US5188963A (en) *	1989-11-17	1993-02-23	Gene Tec Corporation	Device for processing biological specimens for analysis of nucleic acids
US5362308A (en) *	1990-09-25	1994-11-08	Rutgers, The State University Of New Jersey	Disposable dosage unit for iontophoresis-facilitated transdermal delivery, related devices and processes
US5042555A (en) *	1990-10-01	1991-08-27	Modernfold, Inc.	Floor-supported movable wall panel with height adjustment system
FI923023A7 (fi) *	1990-10-31	1992-06-29	Baxter Int	Lähellään tapahtuvan verisuonittumisen aikaansaava istutemateriaali
US5713888A (en) *	1990-10-31	1998-02-03	Baxter International, Inc.	Tissue implant systems
US5314471A (en) *	1991-07-24	1994-05-24	Baxter International Inc.	Tissue inplant systems and methods for sustaining viable high cell densities within a host
US5344454A (en) *	1991-07-24	1994-09-06	Baxter International Inc.	Closed porous chambers for implanting tissue in a host
WO1993003901A1 (en) *	1991-08-23	1993-03-04	W.R. Grace & Co. - Conn.	Implantable immunoisolated therapeutic devices
US5192310A (en) *	1991-09-16	1993-03-09	Atrium Medical Corporation	Self-sealing implantable vascular graft
US5370681A (en) *	1991-09-16	1994-12-06	Atrium Medical Corporation	Polyumenal implantable organ
US5411550A (en) *	1991-09-16	1995-05-02	Atrium Medical Corporation	Implantable prosthetic device for the delivery of a bioactive material
US5197976A (en) *	1991-09-16	1993-03-30	Atrium Medical Corporation	Manually separable multi-lumen vascular graft
US5443498A (en) *	1991-10-01	1995-08-22	Cook Incorporated	Vascular stent and method of making and implanting a vacsular stent
US5178472A (en) *	1991-12-11	1993-01-12	The Torrington Company	Bearing for mounting on a multi-sided shaft
US5387237A (en) *	1992-07-30	1995-02-07	The University Of Toledo	Bioartificial pancreas
WO1994015663A1 (en) *	1992-12-30	1994-07-21	Brown University Research Foundation	Implantable therapy systems and methods
IT1269286B (it) *	1994-12-23	1997-03-26	Marco Accorsi	Procedimento per la produzione di contenitori del tipo flaconi o simili, con film in materiale sintetico termoformabile, e apparecchiatura per la sua esecuzione
WO1996039993A1 (en) *	1995-06-07	1996-12-19	Gore Hybrid Technologies, Inc.	An implantable containment apparatus for a therapeutical device and method for loading and reloading the device therein

1996
- 1996-06-03 WO PCT/US1996/008380 patent/WO1996039993A1/en not_active Ceased
- 1996-06-03 JP JP9500998A patent/JPH10503964A/ja not_active Ceased
- 1996-06-03 DE DE69630266T patent/DE69630266T2/de not_active Expired - Lifetime
- 1996-06-03 AU AU62511/96A patent/AU6251196A/en not_active Abandoned
- 1996-06-03 EP EP96921249A patent/EP0773753B1/en not_active Expired - Lifetime
- 1996-06-03 CA CA002190628A patent/CA2190628C/en not_active Expired - Lifetime
- 1996-06-07 NL NL1003300A patent/NL1003300C2/nl not_active IP Right Cessation
- 1996-06-07 FR FR9607065A patent/FR2735032B1/fr not_active Expired - Lifetime
1997
- 1997-01-09 US US08/781,119 patent/US5913998A/en not_active Expired - Lifetime
- 1997-07-10 US US08/891,119 patent/US5843069A/en not_active Expired - Lifetime
1998
- 1998-11-30 US US09/201,173 patent/US6471687B2/en not_active Expired - Lifetime

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4378016A (en) *	1981-07-15	1983-03-29	Biotek, Inc.	Artificial endocrine gland containing hormone-producing cells
EP0107222A1 (fr) *	1982-09-24	1984-05-02	Jean-Bernard Professeur Buchs	Prothèse pour organe artificiel hybride
US4479796A (en) *	1982-11-15	1984-10-30	Medtronic, Inc.	Self-regenerating drug administration device
WO1993000127A1 (en) *	1991-06-28	1993-01-07	Brown University Research Foundation	Neural implant system
WO1993000128A1 (en) *	1991-06-28	1993-01-07	Brown University Research Foundation	Renewable neural implant device and method

Also Published As

Publication number	Publication date
EP0773753B1 (en)	2003-10-08
US5913998A (en)	1999-06-22
CA2190628C (en)	2000-05-30
FR2735032A1 (fr)	1996-12-13
CA2190628A1 (en)	1996-12-08
AU6251196A (en)	1996-12-30
US20020049426A1 (en)	2002-04-25
FR2735032B1 (fr)	1998-01-16
DE69630266D1 (de)	2003-11-13
US5843069A (en)	1998-12-01
EP0773753A1 (en)	1997-05-21
WO1996039993A1 (en)	1996-12-19
JPH10503964A (ja)	1998-04-14
US6471687B2 (en)	2002-10-29
DE69630266T2 (de)	2004-09-09
NL1003300A1 (nl)	1996-12-10

Legal Events

Date	Code	Title	Description
1997-02-03	AD1A	A request for search or an international type search has been filed
1997-03-03	RD2N	Patents in respect of which a decision has been taken or a report has been made (novelty report)	Effective date: 19961210
1997-05-01	PD2B	A search report has been drawn up
2016-06-10	MK	Patent expired because of reaching the maximum lifetime of a patent	Effective date: 20160606

Publication	Publication Date	Title
NL1003300C2 (nl)	1997-03-20	Implanteerbare therapeutische inrichting.
NL1003302C2 (nl)	1997-03-20	Werkwijze voor het herhaaldelijk vullen en legen van een buisvormig implanteerbaar opsluitapparaat met een therapeutische inrichting.
US5411550A (en)	1995-05-02	Implantable prosthetic device for the delivery of a bioactive material
EP0604546B1 (en)	2003-01-15	Extruded, controlled porosity implantable multi lumen device and method for making the same
US5980889A (en)	1999-11-09	Cell encapsulating device containing a cell displacing core for maintaining cell viability
AU2020210244B2 (en)	2021-12-02	Implantable apparatus for retention of biological moieties
US5782789A (en)	1998-07-21	Macrochannel phosthetic/delivery patch
US12521047B2 (en)	2026-01-13	Implantable access chamber and associated methods of use
ITMI961171A1 (it)	1997-12-07	Apparecchio di contenimento impiantabile per un dispositivo terapeu- tico e metodo per caricarvi e ricaricarvi il dispositivo stesso